-
Signature
-
/s/ Aaron I. Davis, Chief Executive Officer, MVA Investors, LLC
-
Stock symbol
-
TNGX
-
Transactions as of
-
Jun 6, 2024
-
Transactions value $
-
-$985,880
-
Form type
-
4
-
Date filed
-
6/7/2024, 09:14 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TNGX |
Common Stock |
Sale |
-$456K |
-63K |
-13.03% |
$7.24 |
421K |
Jun 6, 2024 |
Direct |
F1 |
transaction |
TNGX |
Common Stock |
Sale |
-$530K |
-77K |
-18.31% |
$6.88 |
344K |
Jun 7, 2024 |
Direct |
F1, F2 |
holding |
TNGX |
Common Stock |
|
|
|
|
|
5K |
Jun 6, 2024 |
See footnote |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share ("Common Stock"), of Tango Therapeutics, Inc. As to any reporting person that is not a beneficial owner of more than 10% of the outstanding shares of Common Stock, this Form 4 shall not be deemed a concession that such person is subject to Section 16 of the Securities Exchange Act of 1934 with respect to the issuer.